Диссертация (1140944), страница 19
Текст из файла (страница 19)
doi: 10.1016/S01406736(10)60550-8.111 McNeely MJ, Boyko EJ. / Type 2 diabetes prevalence in Asian Americans: resultsof a national health survey // Diabetes Care. 2004 Jan;27(1):66-9. doi:10.2337/diacare.27.1.66112 Mehta JL, Chen J, Hermonat PL, et al. / Lectin-like, oxidized low-densitylipoprotein receptor-1 (LOX-1): a critical player in the development ofatherosclerosis and related disorders // Cardiovasc Res. 2006 Jan;69(1):36-45. doi:10.1016/j.cardiores.2005.09.006113 Miki T, Yuda S, Kouzu H, Miura T. / Diabetic cardiomyopathy: pathophysiologyand clinical features // Heart Fail Rev.
2013 Mar;18(2):149-66. doi:10.1007/s10741-012-9313-3114 Minami M, Kume N, Kataoka H. / Transforming growth factor-beta(1) increasesthe expression of lectin-like oxidized low-density lipoprotein receptor-1 // BiochemBiophys Res Commun. 2000 Jun 7;272(2):357-61.115 Minamino T, Komuro I, Kitakaze M. / Endoplasmic reticulum stress as atherapeutic target in cardiovascular disease // Circ Res.
2010; 107(9):1071–82. CircRes. 2010 Oct 29;107(9):1071-82. doi: 10.1161/CIRCRESAHA.110.227819116 Mizushige K, Yao L, Noma T, et al. / Alteration in left ventricular diastolic fillingand accumulation of myocardial collagen at insulin-resistant prediabetic stage of a130type II diabetic rat model // Circulation. 2000 Feb 29;101(8):899-907.
doi:10.1161/01.CIR.101.8.899117 Mogilenko DA, Kudriavtsev IV, Trulioff AS, et al. / Modified Low DensityLipoprotein Stimulates Complement C3 Expression and Secretion via Liver XReceptor and Toll-like Receptor 4 Activation in Human Macrophages // J BiolChem. 2012 Feb 17;287(8):5954-68. doi: 10.1074/jbc.M111.289322118 Mugabo Y, Li L, Renier G. / The Connection Between C-Reactive Protein (CRP)and Diabetic Vasculopathy.
Focus on Preclinical Findings // Curr Diabetes Rev.2010 Jan;6(1):27-34.119 Nagase M, Hirose S, Sawamura T, Masaki T, Fujita T. / Enhanced expression ofendothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats// Biochem Biophys Res Commun. 1997 Aug 28;237(3):496–498. doi:10.1006/bbrc.1997.7176120 Nichols GA1, Gullion CM, Koro CE, Ephross SA, Brown JB. / The incidence ofcongestive heart failure in type 2 diabetes: an update // Diabetes Care. 2004Aug;27(8):1879-84. doi: 10.2337/diacare.27.8.1879121 Njajou OT, Kanaya AM, Holvoet P, et al.
/ Association between oxidized LDL,obesity and type 2 diabetes in a population-based cohort, the Health Aging andBody Composition study // Diabetes Metab Res Rev. 2009 Nov;25(8):733-9. doi:10.1002/dmrr.1011.122 Nojgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U. /Serum levels of YKL-40 and PIIINP as prognostic markers in patients withalcoholic liver disease // J Hepatol. 2003 Aug;39(2):179–86. doi: 10.1016/S01688278(03)00184-3123 Obradovic MM, Trpkovic A, Bajic V et al. / Interrelatedness between C-reactiveprotein and oxidized low-density lipoprotein // Clin Chem Lab Med. 2015Jan;53(1):29-34.
doi: 10.1515/cclm-2014-0590131124 Ohtsuka S, Kakihana M, Watanabe H, Enomoto T, Ajisaka R, Sugishita Y. /Alterations in left ventricular wall stress and coronary circulation in patients withisolated systolic hypertension // J Hypertens. 1996 Nov;14(11):1349-55.125 Ono M, Sekiya C, Ohhira M, Ohhira M, Namiki M, Endo Y, et al. / Elevated levelof serum Mn-superoxide dismutase in patients with primary biliary cirrhosis:possible involvement of free radicals in the pathogenesis in primary biliarycirrhosis // J Lab Clin Med. 1991 Nov;118(5):476-83.126 Palmieri V, Capaldo B, Russo C, Iaccarino M, Pezzullo S, Quintavalle G, et al. /Uncomplicated type 1 diabetes and preclinical left ventricular myocardialdysfunction: insights from echocardiography and exercise cardiac performanceevaluation//DiabetesResClinPract2008;79(2):262–8.doi:10.1016/j.diabres.2007.09.014127 Parola M, Leonarduzzi G, Robino G, Albano E, Poli G, Dianzani MU.
/ On the roleof lipid pedoxidation in the pathogenesis of liver damage induced by longstandingcholestasis // Free Radic Biol Med. 1996;20(3):351-9.128 Pinzani M, Rombouts K. / Liver fibrosis: from the bench to clinical targets // DigLiver Dis. 2004 Apr;36(4):231-42. doi: 10.1016/j.dld.2004.01.003129 Prior DL, Somaratne JB, Jenkins AJ, et al.
/ Calibrated integrated backscatter andmyocardial fibrosis in patients undergoing cardiac surgery // Open Heart. 2015Aug 25;2(1):e000278. doi: 10.1136/openhrt-2015-000278130 Radovits T, Korkmaz S, Loganathan S, Barnucz E, Bomicke T, Arif R, et al.
/Comparative investigation of the left ventricular pressure-volume relationship in ratmodels of type 1 and type 2 diabetes mellitus // Am J Physiol Heart Circ Physiol2009;297(1):H125–33. doi: 10.1152/ajpheart.00165.2009131 Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. / Inflammation,aspirin, and the risk of cardiovascular disease in apparently healthy men // N Engl JMed. 1997 Apr 3;336(14):973-9. doi: 10.1056/NEJM199704033361401132132 Ridker PM, Danielson E, Fonseca FA, et al.
/ Rosuvastatin to prevent vascularevents in men and women with elevated C-reactive protein // N Engl J Med. 2008Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646133 Rodrigues B, Cam MC, McNeill JH. / Metabolic disturbances in diabeticcardiomyopathy // Mol Cell Biochem. 1998 Mar;180(1-2):53-7.134 Ron D, Walter P. / Signal integration in the endoplasmic reticulum unfolded proteinresponse // Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29.135 Rösen P, Du X, Tschöpe D.
/ Role of oxygen derived radicals for vasculardysfunction in the diabetic heart: prevention by alpha-tocopherol? // Mol CellBiochem. 1998 Nov;188(1-2):103-11.136 Rosenberg WM, Voelker M, Thiel R, et al. / Serum markers detect the presence ofliver fibrosis: a cohort study // Gastroenterology. 2004 Dec;127(6):1704–13.doi:10.1053/j.gastro.2004.08.052137 Rota M, LeCapitaine N, Hosoda T, et al.
/ Diabetes promotes cardiac stem cellaging and heart failure, which are prevented by deletion of the p66shc gene // CircRes. 2006 Jul 7;99(1):42-52. doi: 10.1161/01.RES.0000231289.63468.08138 Russell JC, Proctor SD. / Small animal models of cardiovascular disease: tools forthe study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis //Cardiovasc Pathol 2006;15 (6): 318–30. doi: 10.1016/j.carpath.2006.09.001139 Sanda GM, Deleanu M, Simionescu M, Sima AV.
/ Oxidized LDL induce Creactive protein secretion in human macrophages through mechanisms involvingoxidative stress // Annals of R.S.C.B., 2015;19(3):9-20. DOI: 10.ANN/RSCB2015-0028:RSCB140 Sawamura T, Kume N, Aoyama T, et al. / An endothelial receptor for oxidized lowdensity lipoprotein // Nature. 1997 Mar 6;386(6620):73-7.141 Schneiderhan W, Schmid-Kotsas A, Zhao J, et al. / Oxidized low-densitylipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells andstimulate extracellular matrix synthesis // Hepatology. 2001 Oct;34(4 Pt 1):729-37.doi: 10.1053/jhep.2001.27828133142 Scirica BM, Morrow DA.
/ Is C-reactive protein an innocent bystander orproatherogenic culprit? The verdict is still out // Circulation. 2006 May2;113(17):2128-34;discussion2151.doi:10.1161/CIRCULATIONAHA.105.611350143 Seifert PS, Hugo F, Tranum-Jensen J, Zahringer U, Muhly M, Bhakdi S.
/ Isolationand characterization of a complement-activating lipid extracted from humanatherosclerotic lesions // J Exp Med. 1990 Aug 1; 172(2): 547–557.144 Semeniuk LM, Kryski AJ, Severson DL. / Echocardiographic assessment of cardiacfunction in diabetic db/db and transgenic db/db-hGLUT4 mice // Am J PhysiolHeart Circ Physiol 2002;283 (3):H976–82. doi: 10.1152/ajpheart.00088.2002145 Shaw JE, Sicree RA, Zimmet PZ. / Global estimates of the prevalence of diabetesfor 2010 and 2030 // Diabetes Res Clin Pract.
2010 Jan;87(1):4-14. doi:10.1016/j.diabres.2009.10.007.146 Shih HH, Zhang S, Cao W, Hahn A, Wang J, Paulsen JE, et al. / CRP is a novelligand for the oxidized LDL receptor LOX-1 // Am J Physiol Heart Circ Physiol.2009 May;296(5):H1643-50. doi: 10.1152/ajpheart.00938.2008147 Shimizu M, Umeda K, Sugihara N, et al. / Collagen remodelling in myocardia ofpatients with diabetes // J Clin Pathol. 1993 Jan;46(1):32-6.148 Shivalkar B, Dhondt D, Goovaerts I, Van Gaal L, Bartunek J, Van Crombrugge P,et al.
/ Flow mediated dilatation and cardiac function in type 1 diabetes mellitus //Am J Cardiol 2006;97(1):77– 82. doi: 10.1016/j.amjcard.2005.07.111149 Simmons D, Williams DR, Powell MJ. / Prevalence of diabetes in a predominantlyAsian community: preliminary findings of the Coventry diabetes study // BMJ.1989 Jan 7;298(6665):18-21.150 Singh R, Barden A, Mori T, Beilin L. / Advanced glycation end-products: A review// Diabetologia.
2001 Feb;44(2):129-46. doi: 10.1007/s001250051591151 Sokolow M, Lyon TP. / The ventricular complex in left ventricular hypertrophy asobtained by unipolar precordial and limb leads // Am Heart J. 1949 Feb;37(2):16186.134152 Steinberg, D. / Low density lipoprotein oxidation and its pathobiologicalsignificance // J Biol Chem. 1997 Aug 22;272(34):20963-6.153 Sun H, Koike T, Ichikawa T, et al. / C-reactive protein in atherosclerotic lesions: itsorigin and pathophysiological significance // Am J Pathol. 2005 Oct; 167(4): 1139–1148.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
